Ads
related to: pfizer's- Quality by Design
A holistic, proactive approach
to drug development. Learn more.
- Pharma Services Overview
Download our
free brochure.
- In-house vs. Outsource?
Download this decision-making guide
for biologics development.
- Biologics Development
Increase batch yield and reduce
processing time.
- Pharma Trends Whitepaper
Get a CDMO's perspective on the
pharma trends you need to know.
- Early Development Paper
Learn how we can solve even your
your most complex challenges.
- Quality by Design
Search results
NHS introduces Pfizer’s tafamidis for ATTR-CM treatment
Pharmaceutical Technology via Yahoo Finance· 16 hours agoThe UK's National Health Service (NHS) has introduced Pfizer's tafamidis for transthyretin...
Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer
New York Post· 6 days agoThe lawsuits were filed in state courts across the country, but the agreements don’t completely...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool via Yahoo Finance· 10 hours agoThe drug maker experienced a massive surge in sales and earnings during the COVID-19 pandemic's...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 9 hours agoPfizer bought Tivdak in its acquisition of Seagen. Antibody drug conjugates, or ADCs, send toxic...
Pfizer's next move: Can it break above $30? | Invezz
Invezz· 2 days agoPfizer Inc. (NYSE:PFE) faced a challenging 2023 in the stock market, with its shares plummeting from over $50 to a low of $25. On May 1, 2024, Pfizer...
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 5 days agoStrengths highlight Pfizer's robust product portfolio and global market presence. Weaknesses underscore the challenges in revenue fluctuations and patent...
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Benzinga via Yahoo Finance· 1 day agoThe move, reflected in a recent trademark application, aims to provide medical information,...
2 Beaten-Down Stocks to Buy and Hold for 10 Years
Motley Fool via Yahoo Finance· 4 days agoIts forward yield sits at 5.46%, and it has increased its payouts by some 46% over the past five years. Despite underperforming the market of late,...
Child dies in gene therapy trial; Pfizer pauses study
Becker’s Hospital Review· 7 days agoA boy has died in Pfizer's phase 2 study of its gene therapy candidate for Duchenne muscular dystrophy, a rare genetic disorder that primarily affects boys ...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
